Effects of lysosomotropic agents on insulin interactions with adipocytes. Evidence for a lysosomal pathway for insulin processing and degradation.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000643:Ammonium Chloride / Q000494:pharmacology*; D000818:Animals; D002738:Chloroquine / Q000494:pharmacology*; D004140:Dinitrophenols / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005459:Fluorides / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D051381:Rats; D011972:Receptor, Insulin / Q000187:drug effects / Q000378:metabolism*; D014357:Trypsin / Q000494:pharmacology
D004140:Dinitrophenols; D007328:Insulin; D000643:Ammonium Chloride; D002738:Chloroquine; D011972:Receptor, Insulin; D014357:Trypsin; D005033:Ethylmaleimide; D005459:Fluorides